Avive Solutions
The device, which is not yet cleared by the FDA, alerts bystanders to a potential cardiac event nearby and guides them to the scene.
Also: NexHealth's $15 million Series A, Avive Solutions' $7 million raise and Cyclica's $16.9 million Series B.